Edition:
Deutschland

Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

105.11USD
30 Oct 2020
Change (% chg)

$0.11 (+0.10%)
Prev Close
$105.00
Open
$104.87
Day's High
$105.55
Day's Low
$103.13
Volume
1,469,069
Avg. Vol
1,345,898
52-wk High
$114.19
52-wk Low
$61.62

About

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded... (more)

Buy/Sell

Sell Hold Buy
1.85 Mean rating from 20 analysts

Overall

Beta: 1.57
Market Cap(Mil.): $95,559.38
Shares Outstanding(Mil.): 1,737.44
Dividend: 0.26
Yield (%): 1.93

UPDATE 1-Boston Scientific reports loss as COVID-19 slams demand for medical devices

Oct 28 Boston Scientific Corp swung to a loss in the third quarter from profit a year ago, as demand for its medical devices was hurt by the ongoing COVID-19 pandemic.

EU weighs buying Roche, Abbott rapid COVID tests amid limited supplies

BRUSSELS/ZURICH, Oct 27 European countries are looking at buying millions of COVID-19 rapid tests mostly from Roche and Abbott, an EU document shows, as global production of the tests is stretched by a surge in infections.

Photo

European cities plead for more flu shots as winter looms, pandemic rages

WARSAW/MILAN/VIENNA A surge in demand for vaccines to ward off the winter flu has led to shortages in some European cities, raising the risk of a potentially lethal "twindemic" as COVID-19 cases soar.

UPDATE 1-European cities plead for more flu shots as winter looms, pandemic rages

WARSAW/MILAN/VIENNA, Oct 22 A surge in demand for vaccines to ward off the winter flu has led to shortages in some European cities, raising the risk of a potentially lethal "twindemic" as COVID-19 cases soar.

Quest raises profit forecast as COVID-19 tests demand to jump

Quest Diagnostics Inc raised its full-year earnings expectations on Thursday after a strong quarterly beat and forecast robust demand for COVID-19 tests during the fall season and into 2021.

UPDATE 3-Quest raises profit forecast as COVID-19 tests demand to jump

Oct 22 Quest Diagnostics Inc raised its full-year earnings expectations on Thursday after a strong quarterly beat and forecast robust demand for COVID-19 tests during the fall season and into 2021.

European cities plead for more flu shots as winter looms, pandemic rages

WARSAW/MILAN/VIENNA, Oct 22 A surge in demand for vaccines to ward off the winter flu has led to shortages in some European cities, raising the risk of a potentially lethal "twindemic" as COVID-19 cases spike.

Photo

Breakingviews - Corona Capital: U.S. tests, UK loans, Man U groans

NEW YORK/LONDON/HONG KONG (Reuters Breakingviews) - Corona Capital is a column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights.

Photo

Abbott says COVID-19 test demand to grow in 2021

Abbott Laboratories said it expects demand for its COVID-19 tests to grow in 2021 even if a vaccine is developed and for the business to eventually stabilize into a lucrative new franchise.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.22%
Rohstoffe -0.82%
Industrie -2.33%
Konjunktur abhängige Waren & Dienstleistungen -0.51%
Konjunktur unabhängige Waren & Dienstleistungen +0.06%
Finanzindustrie -0.79%
Pharma -2.12%
Technologie +0.00%